Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-016983
Filing Date
2016-01-05
Accepted
2016-01-05 10:32:52
Documents
2
Period of Report
2016-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2396
2 exgemayel.txt EX-24 3950
  Complete submission text file 0001179110-16-016983.txt   7670
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Issuer) CIK: 0001235010 (see all company filings)

EIN.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address
GEMAYEL GEORGES (Reporting) CIK: 0001256088 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50797 | Film No.: 161320436